| Descriptor English: | Adrenal Hyperplasia, Congenital | ||||
| Descriptor Spanish: |
Hiperplasia Suprarrenal Congénita
| ||||
| Descriptor Portuguese: | Hiperplasia Suprarrenal Congênita | ||||
| Descriptor French: | Hyperplasie congénitale des surrénales | ||||
| Entry term(s): |
Adrenal Hyperplasias, Congenital Congenital Adrenal Hyperplasia Congenital Adrenal Hyperplasias Hyperplasia, Congenital Adrenal Hyperplasias, Congenital Adrenal |
||||
| Tree number(s): |
C12.050.351.875.253.090.500 C12.200.706.316.090.500 C12.800.316.090.500 C16.131.939.316.129.500 C16.320.033 C16.320.565.925.249 C18.452.648.925.249 C19.053.440 C19.391.119.090.500 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000312 | ||||
| Scope note: | A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. |
||||
| Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||
| Public MeSH Note: | 80; was ADRENOGENITAL SYNDROME 1963-79 |
||||
| Online Note: | use ADRENAL HYPERPLASIA, CONGENITAL to search ADRENOGENITAL SYNDROME 1966-79 |
||||
| History Note: | 80; was ADRENOGENITAL SYNDROME 1963-79 |
||||
| Entry Version: | ADRENAL HYPERPLASIA CONGEN |
||||
| Related: |
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
MeSH Puberty, Precocious MeSH Steroid 11-beta-Hydroxylase MeSH Steroid 17-alpha-Hydroxylase MeSH Steroid 21-Hydroxylase MeSH Virilism MeSH | ||||
| DeCS ID: | 315 | ||||
| Unique ID: | D000312 | ||||
| NLM Classification: | WK 700 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 1980/01/01 | ||||
| Date of Entry: | 1999/01/01 | ||||
| Revision Date: | 2018/06/30 |
|
|
Adrenal Hyperplasia, Congenital
- Preferred
| Concept UI |
M0000487 |
| Scope note | A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. |
| Preferred term | Adrenal Hyperplasia, Congenital |
| Entry term(s) |
Adrenal Hyperplasias, Congenital Congenital Adrenal Hyperplasia Congenital Adrenal Hyperplasias Hyperplasia, Congenital Adrenal Hyperplasias, Congenital Adrenal |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
